)
Tata Chemicals (TATACHEM) investor relations material
Tata Chemicals Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Standalone Q2 revenue rose 8% YoY to ₹1,303 crore and EBITDA increased to ₹392 crore, while PAT fell to ₹122 crore; consolidated Q2 revenue rose 8% to ₹4,177 crore, with a ₹50 crore net loss.
Lower overseas realizations, higher U.K. energy and logistics costs, and Kenya’s suspension pressured consolidated results.
Priorities include cost competitiveness, reliability, supply-chain resilience, working-capital optimization, and disciplined capital allocation.
Financial highlights
Q2 consolidated EBITDA was ₹381 crore versus ₹537 crore; revenue increased ₹300 crore YoY, including ₹272 crore from volume and mix and ₹28 crore from price.
H1 consolidated revenue rose 11% to ₹8,432 crore; EBITDA was ₹936 crore versus ₹1,186 crore, and PAT before exceptional items and NCI was ₹10 crore versus ₹535 crore.
H1 standalone revenue rose 9% to ₹2,584 crore and EBITDA increased 29% to ₹656 crore; PAT was ₹465 crore, down 4%.
Consolidated Q2 PBT was a loss of ₹6 crore versus a profit of ₹301 crore YoY.
Outlook and guidance
Global soda ash markets are expected to remain challenging and range-bound near term amid oversupply, China capacity additions and sustained exports; sustained price improvement depends on supply rationalization and stronger demand.
Demand support is expected from solar glass, lithium, food and pharma; Living Essentials benefits from premiumization and food, feed, pharma and beverage applications.
Current-year CapEx budget is around ₹1,000 crore, including growth projects; next-year spend is expected to be similar.
LIFE strategy direction is toward more stable, non-cyclical and application-led businesses.
- Revenue up 14% YoY to ₹4,255 crore, but margins and PAT declined amid global pricing pressures.TATACHEM
Q1 26/27 - Net loss of ₹1,715 crore driven by US impairment, but leverage low and dividend maintained.TATACHEM
Q4 25/26 - Soda ash oversupply and weak prices drove losses, but India and expansions support future growth.TATACHEM
Q3 25/26 - India growth offset by weak global prices and UK closure; ₹1,500 crore NCD fund raise approved.TATACHEM
Q2 25/26 - Q1 FY26 saw higher profit and margins despite flat demand and global oversupply.TATACHEM
Q1 25/26 - Q2 FY25 revenue ₹3,999 crore, net profit ₹267 crore, expansions ramping up post-rains.TATACHEM
Q2 24/25 - Sequential revenue and EBITDA growth, but year-over-year declines amid European market headwinds.TATACHEM
Q1 24/25 - FY25 profit declined on lower realisation and UK impairments; dividend of ₹11.00 proposed.TATACHEM
Q4 24/25 - Revenue and profit fell on low prices and UK closure; net debt and risks increased.TATACHEM
Q3 24/25
)
)
)
)
)
)
)
)